Latest: FDA Approves New Biosimilar for Oncology Treatment

Opinion: Keeping pregnant participants out of medical research is more dangerous than including them

0 Mins
The inclusion of pregnant participants in RCTs has remained flat over the past 15 years. Changing this norm will require institutional-level reforms.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago